Laboratório de Papilomavírus, Seção de virologia, Instituto Evandro Chagas, Rodovia BR 316 km 07, Ananindeua, Pará, Brazil.
Instituto Nacional de Câncer (INCA), Clinical Research Coordination, Rua André Cavalcanti, 37, 20231-050 Rio de Janeiro, RJ, Brazil.
Infect Agent Cancer. 2014 Aug 5;9:25. doi: 10.1186/1750-9378-9-25. eCollection 2014.
The main cause of cervical cancer in the world is high risks human papillomavirus infection (mainly represented by HPV-16 and HPV-18), that are associated to the development of malign transformation of the epithelium. HPV prevalence exhibits a wide geographical variability and HPV-16 variants have been related to an increased risk of developing cervical intraepithelial lesion. The aim of this study was to describe DNA-HPV prevalence and HPV-16 variants among a women population from Northern Brazil.
One hundred and forty three women, during routine cervical cancer screening, at Juruti Project, fulfilled an epidemiological inquiry and were screened through a molecular HPV test. HPV-16 variants were determined by sequencing the HPV-16 E6 open reading frame.
Forty two samples were considered HPV positive (29.4%). None of those had abnormal cytology results. HPV prevalence varied between different age groups (Z(U) = 14.62; p = <0.0001) and high-risk HPVs were more frequent among younger ages. The most prevalent type was HPV-16 (14%) and it variants were classified, predominantly, as European (87.5%).
HPV prevalence in our population was higher than described by others and the most prevalent HPV types were high-risk HPVs. The European HPV-16 variant was the most prevalent among HPV-16 positive samples. Our study reinforces the fact that women with normal cytology and a positive molecular test for high-risk HPVs should be submitted to continuous follow up, in order to verify persistence of infection, promoting an early diagnosis of cervical cancer and/or its precursors.
全球范围内宫颈癌的主要病因是高危型人乳头瘤病毒(HPV)感染(主要以 HPV-16 和 HPV-18 为主),这与上皮恶变的发展有关。HPV 的流行具有广泛的地理变异性,HPV-16 变体与发展为宫颈上皮内瘤变的风险增加有关。本研究旨在描述巴西北部地区女性人群中 DNA-HPV 的流行情况和 HPV-16 变体。
在 Juruti 项目中,143 名女性在常规宫颈癌筛查期间完成了一项流行病学调查,并通过分子 HPV 检测进行了筛查。通过对 HPV-16 E6 开放阅读框进行测序来确定 HPV-16 变体。
42 个样本被认为 HPV 阳性(29.4%)。这些样本中没有细胞学异常的结果。HPV 的流行率在不同年龄组之间存在差异(U 检验 Z=14.62,p<0.0001),并且年轻年龄组中高危型 HPV 更为常见。最常见的类型是 HPV-16(14%),其变体主要分为欧洲型(87.5%)。
我们人群中的 HPV 流行率高于其他人的描述,最常见的 HPV 类型是高危型 HPV。在 HPV-16 阳性样本中,最常见的是欧洲型 HPV-16 变体。我们的研究再次证实了这样一个事实,即细胞学正常但分子检测高危型 HPV 阳性的女性应接受持续随访,以验证感染的持续性,从而尽早诊断宫颈癌及其前体。